The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.
Read more About the Cancer Biomarkers Research Group.
Alliance of Pancreatic Cancer Consortia, and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting
This meeting will be held virtually via Zoom on Thursday, May 25 from 8:00 a.m. - 2:30 p.m. ET and Friday, May 26 from 8:00 a.m. - 12:30 p.m. ET. Registration is required.
News and Events
Eliminating Underlying Liver Disease Remains Key Strategy for Liver Cancer Prevention
Date Posted: May 4, 2023
Program Director Position Available
Date Posted: November 10, 2022
Engineering Synthetic Biomarkers for Early Detection of Cancers
Date Posted: February 9, 2022
Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022